ロード中...
Natural Polymorphisms Conferring Resistance to HCV Protease and Polymerase Inhibitors in Treatment-Naïve HIV/HCV Co-Infected Patients in China
BACKGROUND: The advent of direct-acting agents (DAAs) has improved treatment of HCV in HIV co-infection, but may be limited by primary drug resistance. This study reports the prevalence of natural polymorphisms conferring resistance to NS3/4A protease inhibitors and NS5B polymerase inhibitors in tre...
保存先:
| 出版年: | PLoS One |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Public Library of Science
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4920402/ https://ncbi.nlm.nih.gov/pubmed/27341031 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0157438 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|